Dr. Mathias is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9552 Park Meadows Dr
Ste 100
Littleton, CO 80124Phone+1 720-553-2255Fax+1 720-848-5079- Is this information wrong?
Education & Training
- University of ColoradoFellowship, Surgical Retina and Vitreous, 2012 - 2014
- University of ColoradoResidency, Ophthalmology, 2009 - 2012
- Ohio State University HospitalInternship, Internal Medicine, 2008 - 2009
- Ohio State University College of MedicineClass of 2008
Certifications & Licensure
- CO State Medical License 2012 - 2025
- OH State Medical License 2008 - 2010
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- 4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP) Start of enrollment: 2020 Jun 09
Publications & Presentations
PubMed
- Association Between Quantitative and Qualitative Imaging Biomarkers and Geographic Atrophy Growth Rate.Zafar Gill, Andres Lisker-Cervantes, Ramya Gnanaraj, Nathan Grove, Jennifer L Patnaik, Anne M Lynch, Talisa E de Carlo Forest, Alan G Palestine, Marc Mathias, Niranjan...> ;American Journal of Ophthalmology. 2024 Mar 27
- A case of venous overload choroidopathy in the setting of superior vena cava syndrome.Alejandro Itzam Marin, Carson C Petrash, Austin Jolly, William S Gange, Marc T Mathias> ;American Journal of Ophthalmology Case Reports. 2023 Dec 1
- 2 citationsClassification and Growth Rate of Chorioretinal Atrophy after Voretigene Neparvovec-Rzyl for RPE65-Mediated Retinal Degeneration.Nikhil Bommakanti, Benjamin K Young, Robert A Sisk, Audina M Berrocal, Jacque L Duncan, Benjamin Bakall, Marc T Mathias, Ishrat Ahmed, Sarah Chorfi, Jason Comander, Aa...> ;Ophthalmology. Retina. 2024 Jan 1
- Join now to see all
Press Mentions
- 4D Molecular Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of 4D-125 by Intravitreal Injection for the Treatment of X-linked Retinitis PigmentosaAugust 19th, 2020
- University of Colorado Ophthalmologists Administer Novel Treatment for Single Patient Facing Rare Genetic ConditionSeptember 7th, 2023
Hospital Affiliations
- Children's Hospital ColoradoAurora, Colorado
- University of Colorado HospitalAurora, Colorado
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: